---
title: "Netupitant/Palonosetron (Akynzeo(r))"
ocid: "ocds-r6ebe6-0000515969"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000515969"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000515969.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000515969.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2017-11-28"
---

# Netupitant/Palonosetron (Akynzeo(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000515969

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000515969)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000515969.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland (NSS), recently completed the procurement process for the supply of Netupitant/Palonosetron 300 mg/0.5 mg capsules (Akynzeo®) to health boards across NHS Scotland. This procurement falls under the goods category and was undertaken through a limited tender method, which did not involve prior publication of a call for competition. The contract was awarded with an active status on 17th November 2017, and delivery is targeted to various entities linked to the National Health Service in Scotland.

This procurement presents significant opportunities for pharmaceutical companies specialising in branded medicines, particularly those with capacity to supply exclusive products under patent protections. Firms that provide health-related goods, especially oncology medications, would be well-placed to compete in such tenders. Participation in this framework agreement can enhance business growth potential by establishing long-term relationships with NHS entities across Scotland, fostering future collaboration and procurement opportunities.

## Notice

The supply of Netupitant/Palonosetron 300 mg/0.5 mg capsules (Akynzeo(r)) to health boards across NHS Scotland.

### Lot Information

Lot 1

Supply of Netupitant/Palonosetron 300 mg/0.5 mg capsules (Akynzeo(r)) to health boards across NHS Scotland.

### Procurement Information

The medicine awarded to this framework agreement is, and will remain to be, protected by patent for the duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV302731 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Nov 2017 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 17 Nov 2017 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 28 Nov 2017 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV302731
- 6 Nov 2017 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV300479

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV300479
  Aprepitant Akynzeo(r) - The supply of Aprepitant Akynzeo(r) 300 mg/0.5 mg capsules to health boards across NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV302731
  Netupitant/Palonosetron (Akynzeo(r)) - The supply of Netupitant/Palonosetron 300 mg/0.5 mg capsules (Akynzeo(r)) to health boards across NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000515969

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000515969. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000515969.json.